Trials / Conditions / Platelet Aggregation Inhibitors

Platelet Aggregation Inhibitors

23 registered clinical trials studyying Platelet Aggregation Inhibitors — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB NCT06535568	Fondazione Ricerca e Innovazione Cardiovascolare ETS	N/A
Not Yet Recruiting	Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagre NCT07203846	Collegium Medicum w Bydgoszczy	Phase 4
Recruiting	Algorithm-based Tailoring of Dual Antiplatelet Therapy to Improve Outcomes Following Percutaneous Coronary Int NCT05732701	Insel Gruppe AG, University Hospital Bern	N/A
Recruiting	Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabet NCT05702463	Montreal Heart Institute	Phase 1
Unknown	AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE NCT04796714	University Hospital, Bordeaux	Phase 4
Unknown	Correct Timing of Head Imaging in Trauma NCT05306951	University of Padova	—
Completed	Ticagrelor in Elderly Patients Undergoing Percutaneous Coronary Intervention NCT04999293	The First Affiliated Hospital of Dalian Medical University	—
Completed	Pharmacodynamics and Pharmacokinetics of Aspirin Inhalation Powder With Non-Enteric-Coated Chewable Aspirin NCT04328883	Inova Health Care Services	Phase 1
Unknown	Maintenance Of aNtiplatElet Therapy in Patients With Coronary Stenting Undergoing Surgery (MONET BRIDGE) NCT03862651	Ospedale Santa Croce-Carle Cuneo	Phase 2
Completed	The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel NCT03599284	Jiangsu vcare pharmaceutical technology co., LTD	Phase 2
Active Not Recruiting	ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS NCT03462498	Kyoto University, Graduate School of Medicine	Phase 4
Unknown	Management and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia NCT03288441	Maastricht University Medical Center	—
Completed	GLOBAL LEADERS Adjudication Sub-Study NCT03231059	Insel Gruppe AG, University Hospital Bern	—
Completed	The Compliance of DAPT and Statins on Clinical Outcomes in Percutaneous Coronary Intervention Patients NCT03785509	Samsung Medical Center	—
Completed	Predischarge Bundle to Minimize Negative Impact on Quality of Life of Nuisance Bleedings NCT02554006	University Hospital of Ferrara	N/A
Completed	GM03 - Platelet RNA Signatures of Aspirin NCT05278637	Duke University	EARLY_Phase 1
Completed	Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction NCT02808767	Faculty Hospital Kralovske Vinohrady	Phase 4
Completed	ACCEL-LOADING-ACS Study NCT01354808	Gyeongsang National University Hospital	Phase 4
Unknown	Plavix, Prasugrel and Drug Eluting Stents Pilot Trial NCT01103843	St. Francis Hospital, New York	N/A
Completed	The Influence of CYP2C19 Polymorphism and Clinical Outcomes in Stroke Patients NCT02711410	National Cerebral and Cardiovascular Center, Japan	—
Completed	WOEST ( What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Cor NCT00769938	R&D Cardiologie	Phase 4
Completed	Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study) NCT00799396	University of Maryland, Baltimore	Phase 4
Completed	Efficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment Elevation NCT00325390	Sanofi	Phase 3